Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for targeted cancer therapies. Its boronic acid functional group enables participation in Suzuki-Miyaura cross-coupling reactions, allowing efficient construction of complex organic molecules. Commonly employed in medicinal chemistry for modifying heterocyclic scaffolds to enhance biological activity and selectivity. Also utilized in the preparation of protease inhibitors and anti-inflammatory agents due to its ability to stabilize transition-state analogs in enzyme inhibition.